Citation Impact
Citing Papers
The C. elegans heterochronic gene lin-28 coordinates the timing of hypodermal and somatic gonadal programs for hermaphrodite reproductive system morphogenesis
2019 StandoutNobel
Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect
2012
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
2017
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
2014
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Outcome of Vaginoplasty in Male-to-Female Transgenders: A Systematic Review of Surgical Techniques
2015
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Outcome of Vaginoplasty in Male-to-Female Transgenders: A Systematic Review of Surgical Techniques
2015
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Targeting Vascular Pericytes in Hypoxic Tumors Increases Lung Metastasis via Angiopoietin-2
2015
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017 Standout
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
2012
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
mRNA Cancer Vaccines—Messages that Prevail
2017
Transgender people: health at the margins of society
2016 Standout
Global health burden and needs of transgender populations: a review
2016 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Autophagy and the Integrated Stress Response
2010 Standout
The European Regulatory Environment of RNA-Based Vaccines
2016
Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α
2007 StandoutNobel
Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways
2016
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
The role of autophagy in neurodegenerative disease
2013 Standout
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
2007 StandoutNobel
Nociceptive Signals Induce Trafficking of TRPA1 to the Plasma Membrane
2009 StandoutNobel
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
mRNA
2013
An ionizable lipid toolbox for RNA delivery
2021 StandoutNobel
Targeted therapies in bladder cancer: an overview of in vivo research
2015
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
2015 StandoutNobel
Serving transgender people: clinical care considerations and service delivery models in transgender health
2016
Phospholipase Cɛ regulates ovulation in Caenorhabditis elegans
2004
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
2012
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines
2016
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
A novel, disruptive vaccination technology
2013
mRNA vaccines manufacturing: Challenges and bottlenecks
2021
The ReNAissanCe of mRNA-based cancer therapy
2014
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Bladder cancer
2016 Standout
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
2011 StandoutNobel
Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
2010
Materials for non-viral intracellular delivery of messenger RNA therapeutics
2015
Recent innovations in mRNA vaccines
2016
Methods in Mammalian Autophagy Research
2010 Standout
PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
2005
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 Standout
Autophagy and Aging
2011 Standout
Urinary Retention, Incontinence, and Dysregulation of Muscarinic Receptors in Male Mice Lacking Mras
2015
A Novel Protein Kinase A-independent, β-Arrestin-1-dependent Signaling Pathway for p38 Mitogen-activated Protein Kinase Activation by β2-Adrenergic Receptors
2008
The Physiology of Glucagon-like Peptide 1
2007 Standout
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
2014
G-protein signaling: back to the future
2005
PIEZO2 in sensory neurons and urothelial cells coordinates urination
2020 StandoutNatureNobel
Therapeutic vaccines for cancer: an overview of clinical trials
2014
Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks
2006 Standout
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
2016
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
2017
Integration of calcium and RAS signalling
2002
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
2008
mRNA Cancer Vaccines
2016
Molecular biology and targeted therapies for urothelial carcinoma
2015
Linking Rap to cell adhesion
2005
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Epac: A New cAMP-Binding Protein in Support of Glucagon-Like Peptide-1 Receptor-Mediated Signal Transduction in the Pancreatic β-Cell
2004
Crucial Role of Phospholipase Cε in Chemical Carcinogen-Induced Skin Tumor Development
2004
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
mRNA Vaccine Delivery Using Lipid Nanoparticles
2016
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
2013
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
Spermidine in health and disease
2018 StandoutScience
Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals
2017
Biomaterials for mRNA delivery
2015
The 'anti-hype' vaccine
2017
Micromanaging insulin secretion
2004 StandoutNobel
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Willingness to Participate in Mammography Screening
2015
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond
2015
Works of F. vom Dorp being referenced
Angiogenic Switch of Angiopietins-Tie2 System and Its Prognostic Value in Bladder Cancer
2008
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
2015
Epac- and Ca2+-controlled Activation of Ras and Extracellular Signal-regulated Kinases by Gs-coupled Receptors
2004
Stimulation of Phospholipase C-ε by the M3Muscarinic Acetylcholine Receptor Mediated by Cyclic AMP and the GTPase Rap2B
2002
Inhibition of phospholipase C-ε by Gi-coupled receptors
2004
A new phospholipase-C–calcium signalling pathway mediated by cyclic AMP and a Rap GTPase
2001
The Impact of the Receptor of Hyaluronan-Mediated Motility (RHAMM) on Human Urothelial Transitional Cell Cancer of the Bladder
2013
Die Patientenaufklärung zur Prostatakarzinomfrüherkennung ist unzureichend*
2009
Gender reassignment surgery - a 13 year review of surgical outcomes
2012
7046 POSTER Final Analysis of a Phase l/lla Study With CV9103, an Intradermally Administered Prostate Cancer Immunotherapy Based on Self Adjuvanted mRNA
2011
Final analysis of a phase I/IIa study with CV9103, an intradermally administered prostate cancer immunotherapy based on self-adjuvanted mRNA.
2011
Prospective randomized double‐blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE ( AUO‐AB 31/05)
2013
Rap2B-Dependent Stimulation of Phospholipase C-ε by Epidermal Growth Factor Receptor Mediated by c-Src Phosphorylation of RasGRP3
2004